By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cypress Bioscience said that it has received a positive coverage determination from a Medicare administrator for its testing service aimed at helping physicians prescribe a rheumatoid arthritis therapy.

The San Diego-based firm said that Palmetto GBA, an administrator for Medicare Part B in California, issued the positive coverage determination for its Avise PG testing service. The testing service helps physicians make decisions regarding methotrexate therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.